Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001744329-24-000003 0001744329 XXXXXXXX LIVE 1 Common Stock 09/17/2024 false 0000811641 452525306 IMMUCELL CORP /DE/ 56 EVERGREEN DR 56 EVERGREEN DR PORTLAND ME 04103 SRK CAPITAL, LLC (610) 424-1017 206 South Avenue Ste 8 Media PA 19063 SEAN KIRKWOOD (610) 424-1017 206 South Avenue Ste 8 Media PA 19063 0001744329 N SRK FUND I, LP WC N DE 502258.00 502258.00 502258.00 N 6.4 PN Percentage calculated based on 7,833,080 shares of common stock, par value $0.10 per share, outstanding as of August 2, 2024, as reported in the Form 10-Q for the fiscal quarter ended June 30, 2024 of ImmuCell Corporation. Y SRK Capital, LLC OO N PA 502258.00 502258.00 502258.00 N 6.4 OO Percentage calculated based on 7,833,080 shares of common stock, par value $0.10 per share, outstanding as of August 2, 2024, as reported in the Form 10-Q for the fiscal quarter ended June 30, 2024 of ImmuCell Corporation. Y Sean Kirkwood OO N X1 502258.00 502258.00 502258.00 N 6.4 OO Percentage calculated based on 7,833,080 shares of common stock, par value $0.10 per share, outstanding as of August 2, 2024, as reported in the Form 10-Q for the fiscal quarter ended June 30, 2024 of ImmuCell Corporation. Common Stock IMMUCELL CORP /DE/ 56 EVERGREEN DR 56 EVERGREEN DR PORTLAND ME 04103 The shares purchased by SRK Fund were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted. The aggregate purchase price of the 502,258 Shares beneficially owned by SRK Fund is approximately $2,430,957. As of the date hereof, SRK Fund beneficially owned 502,258 Shares. Representing approximately 6.4% of the outstanding shares. SRK Capital, as the general partner of SRK Fund, may be deemed the beneficial owner of the 502,258 Shares owned by SRK Fund. Representing approximately 6.4% of the outstanding shares. Mr. Kirkwood, as the sole owner, member, and manager of SRK Capital, may be deemed the beneficial owner of the 502,258 Shares owned by SRK Fund. Representing approximately 6.4% of the outstanding shares. SRK Fund: 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 502,258 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 502,258 SRK Capital: 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 502,258 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 502,258 Mr. Kirkwood: 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 502,258 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 502,258 This Schedule sets forth information with respect to each purchase and sale of shares of Common Stock which were effectuated by the Reporting Person within the past sixty (60) days. All transactions were effectuated in the open market through a broker. Where the price reported in the column titled "Price Per Share ($)" is a weighted average price. The Reporting Persons will undertake to provide to the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold or purchased at each separate price. Trade Date Shares Purchased Price Per Share ($) 7/19/2024 3,900 4.19 7/25/2024 7,200 4.08 8/02/2024 22,900 3.99 8/05/2024 5,622 3.72 8/06/2024 2,446 3.89 8/08/2024 5,701 3.70 8/13/2024 100 3.82 8/22/2024 4,900 3.55 8/27/2024 6,810 3.85 8/29/2024 16,601 3.80 9/10/2024 1,000 3.85 9/17/2024 12,000 3.48 To the knowledge of any of the Reporting Persons, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares reported in this Item 5. Not applicable. SRK FUND I, LP SRK Capital, LLC general partner 09/17/2024 Sean Kirkwood Authorized Signatory 09/17/2024 SRK Capital, LLC Sean Kirkwood manager 09/17/2024 Sean Kirkwood Sean Kirkwood Sean Kirkwood 09/17/2024